Innate immunity modulation by the IL-33/ST2 system in intestinal mucosa

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  García Miguel, Marina ^a   González, M Julieta ^a   Quera, Rodrigo ^b   Hermoso, Marcela A ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; RECEPTOR PROTEIN; ST2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ANTIGEN RECOGNITION; ANTIINFLAMMATORY ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; GENE CONTROL; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE MUCOSA; REVIEW; ULCERATIVE COLITIS; ANIMAL; BACTERIA; CHRONIC DISEASE; IMMUNOLOGY; MICROBIOLOGY; MUCOSAL IMMUNITY; PATHOLOGY; BACTERIUM;

ANIMALS; BACTERIA; CHRONIC DISEASE; COLITIS, ULCERATIVE; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTERLEUKINS; INTESTINAL MUCOSA; RECEPTORS, CELL SURFACE;

EID: 84874594379     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/142492     Document Type: Review

References (172)

1. Beltrán C. J., Núñez L. E., Díaz- Jiménez D., Farfan N., Candia E., Heine C., López F., González M. J., Quera R., Hermoso M. A., Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflammatory Bowel Diseases 2010 16 7 1097 1107 2-s2.0-77953721901 10.1002/ibd.21175
2. Díaz-Jiménez D., Núñez L. E., Beltrán C. J., Candia E., Suazo C., Álvarez-Lobos M., González M. J., Hermoso M. A., Quera R., Soluble ST2: a new and promising activity marker in ulcerative colitis. World Journal of Gastroenterology 2011 17 17 2181 2190 2-s2.0-79955857793 10.3748/wjg.v17.i17.2181
3. McGuckin M. A., Lindén S. K., Sutton P., Florin T. H., Mucin dynamics and enteric pathogens. Nature Reviews Microbiology 2011 9 4 265 278 2-s2.0-79952756170 10.1038/nrmicro2538
4. McAuley J. L., Linden S. K., Chin W. P., King R. M., Pennington H. L., Gendler S. J., Florin T. H., Hill G. R., Korolik V., McGuckin M. A., MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. Journal of Clinical Investigation 2007 117 8 2313 2324 2-s2.0-34547678389 10.1172/JCI26705 (Pubitemid 47219576)
5. Gendler S. J., Spicer A. P., Epithelial mucin genes. Annual Review of Physiology 1995 57 607 634 2-s2.0-0028942855
6. Atuma C., Strugala V., Allen A., Holm L., The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. American Journal of Physiology 2001 280 5 G922 G929 2-s2.0-0035026232
7. Gum J. R. Jr., Crawley S. C., Hicks J. W., Szymkowski D. E., Kim Y. S., MUC17, a novel membrane-tethered mucin. Biochemical and Biophysical Research Communications 2002 291 3 466 475 2-s2.0-0036297545 10.1006/bbrc.2002.6475 (Pubitemid 34687369)
8. Deplancke B., Gaskins H. R., Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. American Journal of Clinical Nutrition 2001 73 6 1131S 1141S 2-s2.0-0034994474 (Pubitemid 32496957)
9. Karam S. M., Lineage commitment and maturation of epithelial cells in the gut. Frontiers in Bioscience 1999 4 D286 298 2-s2.0-0033558504
10. Milano J., McKay J., Dagenais C., Foster-Brown L., Pognan F., Gadient R., Jacobs R. T., Zacco A., Greenberg B., Ciaccio P. J., Modulation of Notch processing by γ -secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicological Sciences 2004 82 1 341 358 2-s2.0-8444247084 10.1093/toxsci/kfh254 (Pubitemid 39485346)
11. Zheng X., Tsuchiya K., Okamoto R., Iwasaki M., Kano Y., Sakamoto N., Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflammatory Bowel Diseases 2011 17 2251 2260
12. Noah T. K., Kazanjian A., Whitsett J., Shroyer N. F., SAM pointed domain ETS factor (SPDEF) regulates terminal differentiation and maturation of intestinal goblet cells. Experimental Cell Research 2010 316 3 452 465 2-s2.0-72149128893 10.1016/j.yexcr.2009.09.020
13. Carlstedt I., Herrmann A., Karlsson H., Sheehan J., Fransson L. A., Hansson G. C., Characterization of two different glycosylated domains from the insoluble mucin complex of rat small intestine. Journal of Biological Chemistry 1993 268 25 18771 18781 2-s2.0-0027194326 (Pubitemid 23273822)
14. Qin J., Li R., Raes J., Arumugam M., Burgdorf K. S., Manichanh C., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010 464 59 65
15. van Passel M. W. J., Kant R., Zoetendal E. G., Plugge C. M., Derrien M., Malfatti S. A., Chain P. S. G., Woyke T., Palva A., de Vos W. M., Smidt H., The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 2011 6 3 2-s2.0-79952294582 10.1371/journal.pone.0016876 e16876
16. Fu J., Wei B., Wen T., Johansson M. E. V., Liu X., Bradford E., Thomsson K. A., McGee S., Mansour L., Tong M., McDaniel J. M., Sferra T. J., Turner J. R., Chen H., Hansson G. C., Braun J., Xia L., Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice. Journal of Clinical Investigation 2011 121 4 1657 1666 2-s2.0-79953307656 10.1172/JCI45538
17. Kim Y. S., Ho S. B., Intestinal goblet cells and mucins in health and disease: recent insights and progress. Current Gastroenterology Reports 2010 12 5 319 330 2-s2.0-77958170401 10.1007/s11894-010-0131-2
18. Bäckhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I., Host-bacterial mutualism in the human intestine. Science 2005 307 5717 1915 1920 2-s2.0-15544369658 10.1126/science.1104816 (Pubitemid 40404694)
19. Mayadas T. N., Wagner D. D., Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proceedings of the National Academy of Sciences of the United States of America 1992 89 8 3531 3535 2-s2.0-0026561993
20. Perez-Vilar J., Hill R. L., The structure and assembly of secreted mucins. Journal of Biological Chemistry 1999 274 45 31751 31754 2-s2.0-0033527547 10.1074/jbc.274.45.31751 (Pubitemid 29522897)
21. Asker N., Baeckstrom D., Axelsson M. A. B., Carlstedt I., Hansson G. C., The human MUC2 mucin apoprotein appears to dimerize before O-glycosylation and shares epitopes with the "insoluble" mucin of rat small intestine. Biochemical Journal 1995 308 3 873 880 2-s2.0-0029006965
22. Asker N., Axelsson M. A. B., Olofsson S. O., Hansson G. C., Dimerization of the human MUC2 mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and dimers to the Golgi apparatus. Journal of Biological Chemistry 1998 273 30 18857 18863 2-s2.0-0032563128 10.1074/jbc.273.30.18857 (Pubitemid 28366272)
23. Van Klinken B. J. W., Einerhand A. W. C., Büller H. A., Dekker J., The oligomerization of a family of four genetically clustered human gastrointestinal mucins. Glycobiology 1998 8 1 67 75 2-s2.0-0031887492 10.1093/glycob/8.1.67 (Pubitemid 28066362)
24. Ambort D., Van Der Post S., Johansson M. E. V., MacKenzie J., Thomsson E., Krengel U., Hansson G. C., Function of the CysD domain of the gel-forming MUC2 mucin. Biochemical Journal 2011 436 1 61 70 2-s2.0-79955537785 10.1042/BJ20102066
25. Velcich A., Yang W., Heyer J., Fragale A., Nicholas C., Viani S., Kucherlapati R., Lipkin M., Yang K., Augenlicht L., Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002 295 5560 1726 1729 2-s2.0-0036500996 10.1126/science.1069094 (Pubitemid 34202910)
26. Johansson M. E. V., Gustafsson J. K., Sjöberg K. E., Petersson J., Holm L., Sjövall H., Hansson G. C., Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS ONE 2010 5 8 2-s2.0-77957906400 10.1371/journal.pone.0012238 e12238
27. Buisine M. P., Desreumaux P., Leteurtre E., Copin M. C., Colombel J. F., Porchet N., Aubert J. P., Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001 49 4 544 551 2-s2.0-0034823196 10.1136/gut.49.4.544 (Pubitemid 32896986)
28. Tytgat K. M. A. J., Van Der Wal J. W. G., Einerhand A. W. C., Büller H. A., Dekker J., Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochemical and Biophysical Research Communications 1996 224 2 397 405 2-s2.0-0030590089 10.1006/bbrc.1996.1039 (Pubitemid 26268199)
29. Van Klinken B. J. W., Van Der Wal J. W. G., Einerhand A., Büller H. A., Dekker J., Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 1999 44 3 387 393 2-s2.0-0032985868 (Pubitemid 29119336)
30. Hanski C., Born M., Foss H. D., Marowski B., Mansmann U., Arastéh K., Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core. Journal of Pathology 1999 188 304 311 (Pubitemid 29317775)
31. Kindon H., Pothoulakis C., Thim L., Lynch-Devaney K., Podolsky D. K., Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995 109 2 516 523 2-s2.0-0029133784 10.1016/0016-5085(95)90340-2
32. Tomasetto C., Masson R., Linares J., Wendling C., Lefebvre O., Chenard M., Rio M., pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 2000 118 1 70 80 2-s2.0-0033970973 (Pubitemid 30020374)
33. Taupin D., Podolsky D. K., Trefoil factors: initiators of mucosal healing. Nature Reviews Molecular Cell Biology 2003 4 9 721 732 2-s2.0-0041837509 10.1038/nrm1203 (Pubitemid 37082187)
34. Grønbæk H., Vestergaard E. M., Hey H., Nielsen J. N., Nexø E., Serum trefoil factors in patients with inflammatory bowel disease. Digestion 2006 74 1 33 39 2-s2.0-33751525342 10.1159/000096591 (Pubitemid 44835689)
35. Longman R. J., Poulsom R., Corfield A. P., Warren B. F., Wright N. A., Thomas M. G., Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. Journal of Histochemistry and Cytochemistry 2006 54 12 1335 1348 2-s2.0-33751250222 10.1369/jhc.5A6904.2006 (Pubitemid 44788819)
36. Artis D., Wang M. L., Keilbaugh S. A., He W., Brenes M., Swain G. P., Knight P. A., Donaldson D. D., Lazar M. A., Miller H. R. P., Schad G. A., Scott P., Wu G. D., RELM β /FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proceedings of the National Academy of Sciences of the United States of America 2004 101 37 13596 13600 2-s2.0-4544300682 10.1073/pnas.0404034101 (Pubitemid 39238448)
37. Nair M. G., Guild K. J., Du Y., Zaph C., Yancopoulos G. D., Valenzuela D. M., Murphy A., Stevens S., Karow M., Artis D., Goblet cell-derived resistin-like molecule β augments CD4+ T cell production of IFN- γ and infection-induced intestinal inflammation. Journal of Immunology 2008 181 7 4709 4715 2-s2.0-58149286587
38. Hogan S. P., Seidu L., Blanchard C., Groschwitz K., Mishra A., Karow M. L., Ahrens R., Artis D., Murphy A. J., Valenzuela D. M., Yancopoulos G. D., Rothenberg M. E., Resistin-like molecule β regulates innate colonic function: barrier integrity and inflammation susceptibility. Journal of Allergy and Clinical Immunology 2006 118 1 257 268 2-s2.0-33745396463 10.1016/j.jaci.2006.04.039 (Pubitemid 43946483)
39. Knight P. A., Brown J. K., Pemberton A. D., Innate immune response mechanisms in the intestinal epithelium: potential roles for mast cells and goblet cells in the expulsion of adult Trichinella spiralis. Parasitology 2008 135 6 655 670 2-s2.0-44349189080 10.1017/S0031182008004319 (Pubitemid 351735871)
40. Johansson M. E. V., Thomsson K. A., Hansson G. C., Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the fcgbp protein. Journal of Proteome Research 2009 8 7 3549 3557 2-s2.0-67650394385 10.1021/pr9002504
41. Albert T. K., Laubinger W., Müller S., Hanisch F. G., Kalinski T., Meyer F., Hoffmann W., Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-associated FCGBP protein and is released by hydrogen sulfide. Journal of Proteome Research 2010 9 6 3108 3117 2-s2.0-77954611767 10.1021/pr100020c
42. Müller C. A., Autenrieth I. B., Peschel A., Innate defenses of the intestinal epithelial barrier. Cellular and Molecular Life Sciences 2005 62 12 1297 1307 2-s2.0-20744443283 10.1007/s00018-005-5034-2 (Pubitemid 40853817)
43. Bevins C. L., Salzman N. H., Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nature Reviews Microbiology 2011 9 5 356 368 2-s2.0-79954915318 10.1038/nrmicro2546
44. Höcker M., Wiedenmann B., Molecular mechanisms of enteroendocrine differentiaton. Annals of the New York Academy of Sciences 1998 859 160 174 2-s2.0-0032406286 10.1111/j.1749-6632.1998.tb11120.x (Pubitemid 29021015)
45. Barton G. M., Medzhitov R., Toll-like receptors and their ligands. Current Topics in Microbiology and Immunology 2002 270 81 92 2-s2.0-0036451205 (Pubitemid 35448154)
46. Medzhitov R., Janeway C. Jr., The Toll receptor family and microbial recognition. Trends in Microbiology 2000 8 10 452 456 2-s2.0-0034307339 10.1016/S0966-842X(00)01845-X
47. Beutler B., Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Current Opinion in Microbiology 2000 3 1 23 28 2-s2.0-0033968116 10.1016/S1369-5274(99)00046-6 (Pubitemid 30094259)
48. Bowie A., O'Neill L. A. J., The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. Journal of Leukocyte Biology 2000 67 4 508 514 2-s2.0-0033861419
49. Rehwinkel J., Tan C. P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., Reis e Sousa C., RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010 140 3 397 408 2-s2.0-75749140581 10.1016/j.cell.2010.01.020
50. Abreu M. T., Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Reviews Immunology 2010 10 2 131 143 2-s2.0-75649093343 10.1038/nri2707
51. Abreu M. T., Vora P., Faure E., Thomas L. S., Arnold E. T., Arditi M., Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. Journal of Immunology 2001 167 3 1609 1616 2-s2.0-0035424901 (Pubitemid 32703162)
52. Cario E., Rosenberg I. M., Brandwein S. L., Beck P. L., Reinecker H. C., Podolsky D. K., Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. Journal of Immunology 2000 164 2 966 972 2-s2.0-0034650930 (Pubitemid 30043724)
53. Hornef M. W., Frisan T., Vandewalle A., Normark S., Richter-Dahlfors A., Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. Journal of Experimental Medicine 2002 195 5 559 570 2-s2.0-0037018107 10.1084/jem.20011788 (Pubitemid 34461501)
54. Hornef M. W., Normark B. H., Vandewalle A., Normark S., Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. Journal of Experimental Medicine 2003 198 8 1225 1235 2-s2.0-0142157000 10.1084/jem.20022194 (Pubitemid 37323387)
55. Lee J., Mo J. H., Katakura K., Alkalay I., Rucker A. N., Liu Y. T., Lee H. K., Shen C., Cojocaru G., Shenouda S., Kagnoff M., Eckmann L., Ben-Neriah Y., Raz E., Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nature Cell Biology 2006 8 12 1327 1336 2-s2.0-33751551466 10.1038/ncb1500 (Pubitemid 44835107)
56. Inohara N., Chamaillard M., McDonald C., Nuñez G., NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annual Review of Biochemistry 2005 74 355 383 2-s2.0-17644366913 10.1146/annurev. biochem.74.082803.133347 (Pubitemid 40995511)
57. Strober W., Murray P. J., Kitani A., Watanabe T., Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Reviews Immunology 2006 6 1 9 20 2-s2.0-33244472793 10.1038/nri1747 (Pubitemid 43279749)
58. Tada H., Aiba S., Shibata K. I., Ohteki T., Takada H., Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infection and Immunity 2005 73 12 7967 7976 2-s2.0-28444471235 10.1128/IAI.73.12.7967-7976. 2005 (Pubitemid 41740282)
59. Fritz J. H., Girardin S. E., Fitting C., Werts C., Mengin-Lecreulx D., Caroff M., Cavaillon J. M., Philpott D. J., Adib-Conquy M., Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2- activating agonists. European Journal of Immunology 2005 35 8 2459 2470 2-s2.0-23844521000 10.1002/eji.200526286 (Pubitemid 41179767)
60. Watanabe T., Kitani A., Murray P. J., Strober W., NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 2004 5 8 800 808 2-s2.0-4444253690 10.1038/ni1092 (Pubitemid 39172973)
61. Kobayashi K. S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nuñez G., Flavell R. A., Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005 307 5710 731 734 2-s2.0-13244292161 10.1126/science.1104911 (Pubitemid 40194644)
62. Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., Almer S., Tysk C., O'morain C. A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J. F., Sahbatou M., Thomas G., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411 6837 599 603 2-s2.0-0035978651 10.1038/35079107 (Pubitemid 32531408)
63. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schäffeler E., Schlee M., Herrlinger K. R., Stallmach A., Noack F., Fritz P., Schröder J. M., Bevins C. L., Fellermann K., Stange E. F., NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α -defensin expression. Gut 2004 53 11 1658 1664 2-s2.0-7244257312 10.1136/gut.2003.032805 (Pubitemid 39434112)
64. Gersemann M., Becker S., Kübler I., Koslowski M., Wang G., Herrlinger K. R., Griger J., Fritz P., Fellermann K., Schwab M., Wehkamp J., Stange E. F., Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. Differentiation 2009 77 1 84 94 2-s2.0-60549086579 10.1016/j.diff.2008.09.008
65. Fahlgren A., Hammarström S., Danielsson A., Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clinical and Experimental Immunology 2003 131 1 90 101 2-s2.0-0037234635 10.1046/j.1365-2249.2003.02035.x (Pubitemid 36098827)
66. O'Neil D. A., Porter E. M., Elewaut D., Anderson G. M., Eckmann L., Ganz T., Kagnoff M. F., Expression and regulation of the human β -defensins hBD-1 and hBD-2 in intestinal epithelium. Journal of Immunology 1999 163 12 6718 6724 2-s2.0-0032734313
67. Hase K., Eckmann L., Leopard J. D., Varki N., Kagnoff M. F., Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infection and Immunity 2002 70 2 953 963 2-s2.0-0036151109 10.1128/IAI.70.2.953-963.2002 (Pubitemid 34083859)
68. Heazlewood C. K., Cook M. C., Eri R., Price G. R., Tauro S. B., Taupin D., Thornton D. J., Chin W. P., Crockford T. L., Cornall R. J., Adams R., Kato M., Nelms K. A., Hong N. A., Florin T. H. J., Goodnow C. C., McGuckin M. A., Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Medicine 2008 5 3, article e54 2-s2.0-41549092745 10.1371/journal.pmed.0050054 (Pubitemid 351471694)
69. Kaser A., Lee A. H., Franke A., Glickman J. N., Zeissig S., Tilg H., Nieuwenhuis E. E. S., Higgins D. E., Schreiber S., Glimcher L. H., Blumberg R. S., XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 2008 134 5 743 756 2-s2.0-50249086073 10.1016/j.cell.2008.07.021
70. Madara J. L., Stafford J., Interferon- γ directly affects barrier function of cultured intestinal epithelial monolayers. Journal of Clinical Investigation 1989 83 2 724 727 2-s2.0-0024553788 (Pubitemid 19061198)
71. Moy A. B., Van Engelenhoven J., Bodmer J., Kamath J., Keese C., Giaever I., Shasby S., Shasby D. M., Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. Journal of Clinical Investigation 1996 97 4 1020 1027 2-s2.0-0030030165 (Pubitemid 26070582)
72. Goeckeler Z. M., Wysolmerski R. B., Myosin light chain kinase-regulated endothelial cell contraction: the relationship between isometric tension, actin polymerization, and myosin phosphorylation. Journal of Cell Biology 1995 130 3 613 627 2-s2.0-0029119895 10.1083/jcb.130.3.613
73. Niess J. H., Brand S., Gu X., Landsman L., Jung S., McCormick B. A., Vyas J. M., Boes M., Ploegh H. L., Fox J. G., Littman D. R., Reinecker H. C., CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005 307 5707 254 258 2-s2.0-12244297799 10.1126/science. 1102901 (Pubitemid 40116240)
74. Umehara H., Bloom E. T., Okazaki T., Nagano Y., Yoshie O., Imai T., Fractalkine in vascular biology: from basic research to clinical disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 1 34 40 2-s2.0-0347123001 10.1161/01.ATV.0000095360.62479.1F (Pubitemid 38082409)
75. Nishimura M., Umehara H., Nakayama T., Yoneda O., Hieshima K., Kakizaki M., Dohmae N., Yoshie O., Imai T., Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by Cx3CR1 expression. Journal of Immunology 2002 168 12 6173 6180 2-s2.0-0037097775 (Pubitemid 34620036)
76. Rutella S., Danese S., Leone G., Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006 108 5 1435 1440 2-s2.0-33748162638 10.1182/blood-2006-03-006403 (Pubitemid 44316106)
77. Ardavín C., Origin, precursors and differentiation of mouse dendritic cells. Nature Reviews Immunology 2003 3 7 582 590 2-s2.0-0142166682 10.1038/nri1127 (Pubitemid 37328677)
78. Coombes J. L., Powrie F., Dendritic cells in intestinal immune regulation. Nature Reviews Immunology 2008 8 6 435 446 2-s2.0-44349167059 10.1038/nri2335 (Pubitemid 351733420)
79. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J. P., Ricciardi-Castagnoli P., Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunology 2001 2 4 361 367 2-s2.0-0035321325 10.1038/86373 (Pubitemid 33706348)
80. Del Prete A., Shao W. H., Mitola S., Santoro G., Sozzani S., Haribabu B., Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 2007 109 2 626 631 2-s2.0-33846245411 10.1182/blood-2006-02- 003665 (Pubitemid 46105963)
81. Rutella S., Locatelli F., Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology 2011 17 3761 3775
82. Hart A. L., Al-Hassi H. O., Rigby R. J., Bell S. J., Emmanuel A. V., Knight S. C., Kamm M. A., Stagg A. J., Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005 129 1 50 65 2-s2.0-22344448660 10.1053/j.gastro.2005.05.013 (Pubitemid 41002042)
83. Smythies L. E., Maheshwari A., Clements R., Eckhoff D., Novak L., Vu H. L., Mosteller-Barnum L. M., Sellers M., Smith P. D., Mucosal IL-8 and TGF- β recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. Journal of Leukocyte Biology 2006 80 3 492 499 2-s2.0-33750488134 10.1189/jlb.1005566 (Pubitemid 44835782)
84. Fukata M., Vamadevan A. S., Abreu M. T., Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Seminars in Immunology 2009 21 4 242 253 2-s2.0-69949105213 10.1016/j.smim.2009.06.005
85. Bortoluci K. R., Medzhitov R., Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cellular and Molecular Life Sciences 2010 67 10 1643 1651 2-s2.0-77949466468 10.1007/s00018-010-0290-1
86. Smith P. D., Smythies L. E., Shen R., Greenwell-Wild T., Gliozzi M., Wahl S. M., Intestinal macrophages and response to microbial encroachment. Mucosal Immunology 2011 4 1 31 42 2-s2.0-78650807608 10.1038/mi.2010.66
87. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P. A., Scholmerich J., Gross V., Nuclear factor B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 1998 115 2 357 369 2-s2.0-0031595210 10.1016/S0016-5085(98)70202-1 (Pubitemid 28363428)
88. Franchi L., Kamada N., Nakamura Y., Burberry A., Kuffa P., Suzuki S., NLRC4-driven production of IL-1beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nature Immunology 2012 13 449 456
89. Candia E., Diaz-Jimenez D., Langjahr P., Nunez L. E., de la Fuente M., Farfán N., Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients. Immunobiology 2012 217 634 642
90. Nicoletti C., Arques J. L., Bertelli E., CX3CR1 is critical for salmonella-induced migration of dendritic cells into the intestinal lumen. Gut Microbes 2010 1 3 131 134 2-s2.0-77954825887
91. Inoue T., Tsuzuki Y., Matsuzaki K., Matsunaga H., Miyazaki J., Hokari R., Okada Y., Kawaguchi A., Nagao S., Itoh K., Matsumoto S., Miura S., Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice. Journal of Leukocyte Biology 2005 77 3 287 295 2-s2.0-20044374989 10.1189/jlb.0204104 (Pubitemid 40289557)
92. Neurath M. F., Fuss I., Schürmann G., Pettersson S., Arnold K., Müller-Lobeck H., Strober W., Herfarth C., Meyer Zum Büschenfelde K. H., Cytokine gene transcription by NF- B family members in patients with inflammatory bowel disease. Annals of the New York Academy of Sciences 1998 859 149 159 2-s2.0-0032437063 10.1111/j.1749-6632.1998.tb11119.x (Pubitemid 29021014)
93. Clarke T. B., Davis K. M., Lysenko E. S., Zhou A. Y., Yu Y., Weiser J. N., Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nature Medicine 2010 16 2 228 231 2-s2.0-76249120134 10.1038/nm.2087
94. Hayashi F., Means T. K., Luster A. D., Toll-like receptors stimulate human neutrophil function. Blood 2003 102 7 2660 2669 2-s2.0-0141705297 10.1182/blood-2003-04-1078 (Pubitemid 37193610)
95. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D. S., Weinrauch Y., Zychlinsky A., Neutrophil extracellular traps kill bacteria. Science 2004 303 5663 1532 1535 2-s2.0-1542287347 10.1126/science.1092385 (Pubitemid 38314426)
96. Egesten A., Eliasson M., Olin A. I., Erjefält J. S., Bjartell A., Sangfelt P., Carlson M., The proinflammatory CXC-chemokines GRO- α /CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. International Journal of Colorectal Disease 2007 22 12 1421 1427 2-s2.0-35148823163 10.1007/s00384-007- 0370-3 (Pubitemid 47543330)
97. Sutherland M., Schewe T., Nigam S., Biological actions of the free acid of hepoxilin A3 on human neutrophils. Biochemical Pharmacology 2000 59 4 435 440 2-s2.0-0033979818 10.1016/S0006-2952(99)00345-7 (Pubitemid 30015973)
98. Mrsny R. J., Gewirtz A. T., Siccardi D., Savidge T., Hurley B. P., Madara J. L., McCormick B. A., Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proceedings of the National Academy of Sciences of the United States of America 2004 101 19 7421 7426 2-s2.0-2442572098 10.1073/pnas.0400832101 (Pubitemid 38638048)
99. MacDermott R. P., Chemokines in the inflammatory bowel diseases. Journal of Clinical Immunology 1999 19 5 266 272 2-s2.0-0032881495 10.1023/A: 1020583306627 (Pubitemid 29489391)
100. Costa F., Mumolo M. G., Ceccarelli L., Bellini M., Romano M. R., Sterpi C., Ricchiuti A., Marchi S., Bottai M., Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005 54 3 364 368 2-s2.0-14544308315 10.1136/gut.2004.043406 (Pubitemid 40299092)
101. Galli S. J., Nakae S., Tsai M., Mast cells in the development of adaptive immune responses. Nature Immunology 2005 6 2 135 142 2-s2.0-13944249962 10.1038/ni1158 (Pubitemid 40268194)
102. Reese T. A., Liang H. E., Tager A. M., Luster A. D., Van Rooijen N., Voehringer D., Locksley R. M., Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007 447 7140 92 96 2-s2.0-34247626970 10.1038/nature05746 (Pubitemid 46685837)
103. Stetson D. B., Voehringer D., Grogan J. L., Xu M., Reinhardt R. L., Scheu S., Kelly B. L., Locksley R. M., Th2 cells: orchestrating barrier immunity. Advances in Immunology 2004 83 163 189 2-s2.0-2442640565 10.1016/S0065-2776(04) 83005-0 (Pubitemid 38657640)
104. Chen W., Paulus B., Shu D., Wilson I., Chadwick V., Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2001 36 5 515 520 2-s2.0-0035055681 (Pubitemid 32328442)
105. Wedemeyer J., Lorentz A. C., Goke M., Meier P. N., Flemming P., Dahinden C. A., Manns M. P., Bischoff S. C., Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut 1999 44 5 629 635 2-s2.0-0033005736 (Pubitemid 29195909)
106. Berstad A., Borkje B., Riedel B., Elsayed S., Berstad A., Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepato- Gastroenterology 1993 40 3 276 278 2-s2.0-0027180157 (Pubitemid 23212181)
107. Coppi L. C., Thomazzi S. M., Ayrizono M. D. L. S., Coy C. S. R., Fagundes J. J., Goes J. R. N., Franchi G. C., Nowill A. E., Monies C. G., Antunes E., Ferraz J. G. P., Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases 2007 13 2 211 218 2-s2.0-34249333049 10.1002/ibd.20018 (Pubitemid 46806230)
108. Levy A. M., Gleich G. J., Sandborn W. J., Tremaine W. J., Steiner B. L., Phillips S. F., Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clinic Proceedings 1997 72 2 117 123 2-s2.0-0031409459 (Pubitemid 28201642)
109. Raab Y., Fredens K., Gerdin B., Hällgren R., Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Digestive Diseases and Sciences 1998 43 5 1061 1070 2-s2.0-0031895124 10.1023/A:1018843104511 (Pubitemid 28211468)
110. He S. H., Key role of mast cells and their major secretory products in inflammatory bowel disease. World Journal of Gastroenterology 2004 10 3 309 318 2-s2.0-1142263309
111. Cenac N., Chin A. C., Garcia-Villar R., Salvador-Cartier C., Ferrier L., Vergnolle N., Buret A. G., Fioramonti J., Bueno L., PAR2 activation alters colonic paracellular permeability in mice via IFN- γ -dependent and -independent pathways. Journal of Physiology 2004 558 3 913 925 2-s2.0-4444377666 10.1113/jphysiol.2004.061721 (Pubitemid 39199112)
112. Nolte H., Spjeldnaes N., Kruse A., Windelborg B., Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut 1990 31 7 791 794 2-s2.0-0025295970 (Pubitemid 20233946)
113. Dvorak A. M., Monahan R. A., Osage J. E., Dickersin G. R., Crohn's disease: transmission electron microscopic studies-II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Human Pathology 1980 11 6 606 619 2-s2.0-0019158285 (Pubitemid 11210404)
114. Lloyd G., Green F. H. Y., Fox H., Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 1975 16 11 861 865 2-s2.0-0016747923
115. Sarin S. K., Malhotra V., Gupta S. S., Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Digestive Diseases and Sciences 1987 32 4 363 367 2-s2.0-0023234155 (Pubitemid 17061264)
116. Bischoff S. C., Wedemeyer J., Herrmann A., Meier P. N., Trautwein C., Cetin Y., Maschek H., Stolte M., Gebel M., Manns M. P., Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996 28 1 1 13 2-s2.0-9044219840 (Pubitemid 26040136)
117. King T., Biddle W., Bhatia P., Moore J., Miner P. B. Jr., Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Digestive Diseases and Sciences 1992 37 4 490 495 2-s2.0-0026586880
118. Levenstein S., Prantera C., Varvo V., Scribano M. L., Berto E., Andreoli A., Luzi C., Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. American Journal of Gastroenterology 1994 89 8 1219 1225 2-s2.0-0028106683 (Pubitemid 24245799)
119. Raithel M., Schneider H. T., Hahn E. G., Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 1999 34 5 496 503 2-s2.0-0033060541 10.1080/003655299750026236 (Pubitemid 29307820)
120. Fox C. C., Lazenby A. J., Moore W. C., Yardley J. H., Bayless T. M., Lichtenstein L. M., Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990 99 1 119 124 2-s2.0-0025301219 (Pubitemid 20202499)
121. Farhadi A., Keshavarzian A., Van De Kar L. D., Jakate S., Domm A., Zhang L., Shaikh M., Banan A., Fields J. Z., Heightened responses to stressors in patients with inflammatory bowel disease. American Journal of Gastroenterology 2005 100 8 1796 1804 2-s2.0-25644449654 10.1111/j.1572-0241.2005.50071.x (Pubitemid 41648436)
122. Santos J., Saperas E., Nogueiras C., Mourelle M., Antolin M., Cadahia A., Malagelada J. R., Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998 114 4 I 640 648 2-s2.0-0031899530 10.1016/S0016-5085(98)70577-3 (Pubitemid 28160398)
123. Havran W. L., Chien Y. H., Allison J. P., Recognition of self antigens by skin-derived T cells with invariant γ δ antigen receptors. Science 1991 252 5011 1430 1432 2-s2.0-0025836121 (Pubitemid 21917062)
124. Schluns K. S., Nowak E. C., Cabrera-Hernandez A., Puddington L., Lefrançois L., Aguila H. L., Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor α expression. Proceedings of the National Academy of Sciences of the United States of America 2004 101 15 5616 5621 2-s2.0-1842782771 10.1073/pnas.0307442101 (Pubitemid 38481205)
125. Boismenu R., Havran W. L., Modulation of epithelial cell growth by intraepithelial γ δ T cells. Science 1994 266 5188 1253 1255 2-s2.0-0028117098 (Pubitemid 24371285)
126. Malinarich F. H., Grabski E., Worbs T., Chennupati V., Haas J. D., Schmitz S., Candia E., Quera R., Malissen B., Förster R., Hermoso M., Prinz I., Constant TCR triggering suggests that the TCR expressed on intestinal intraepithelial γ δ T cells is functional in vivo. European Journal of Immunology 2010 40 12 3378 3388 2-s2.0-78649588502 10.1002/eji.201040727
127. Liu Z. J., Yadav P. K., Xu X., Su J., Chen C., Tang M., Lin H., Yu J., Qian J., Yang P. C., Wang X., The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Journal of Leukocyte Biology 2011 89 4 597 606 2-s2.0-79953703986 10.1189/jlb.0810456
128. Kobayashi T., Okamoto S., Iwakami Y., Nakazawa A., Hisamatsu T., Chinen H., Kamada N., Imai T., Goto H., Hibi T., Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflammatory Bowel Diseases 2007 13 7 837 846 2-s2.0-34547633802 10.1002/ibd.20113 (Pubitemid 47203861)
129. Inagaki-Ohara K., Chinen T., Matsuzaki G., Sasaki A., Sakamoto Y., Hiromatsu K., Nakamura-Uchiyama F., Nawa Y., Yoshimura A., Mucosal T cells bearing TCR γ δ play a protective role in intestinal inflammation. Journal of Immunology 2004 173 2 1390 1398 2-s2.0-3142686026 (Pubitemid 38924320)
130. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S., Functions of natural killer cells. Nature Immunology 2008 9 5 503 510 2-s2.0-42449151214 10.1038/ni1582 (Pubitemid 351560519)
131. Martín-Fontecha A., Thomsen L. L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F., Induced recruitment of NK cells to lymph nodes provides IFN- γ for TH1 priming. Nature Immunology 2004 5 12 1260 1265 2-s2.0-13444262764 10.1038/ni1138 (Pubitemid 41057741)
132. Steel A. W., Mela C. M., Lindsay J. O., Gazzard B. G., Goodier M. R., Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment. Alimentary Pharmacology and Therapeutics 2011 33 1 115 126 2-s2.0-78650029386 10.1111/j.1365-2036.2010.04499.x
133. Shimamoto M., Ueno Y., Tanaka S., Onitake T., Hanaoka R., Yoshioka K., Hatakeyama T., Chayama K., Selective decrease in colonic CD56+ T and CD161+T cells in the inflamed mucosa of patients with ulcerative colitis. World Journal of Gastroenterology 2007 13 45 5995 6002 2-s2.0-36949007400 10.3748/wjg.13.5995 (Pubitemid 350238266)
134. Budagian V., Bulanova E., Paus R., Bulfone-Paus S., IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine and Growth Factor Reviews 2006 17 4 259 280 2-s2.0-33745812074 10.1016/j.cytogfr.2006.05.001 (Pubitemid 44038618)
135. Liu Z. J., Yang L., Cui Y., Wang X., Guo C., Huang Z., Kan Q., Liu Z., Liu Y., IL-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 8 1133 1144 2-s2.0-66149159613 10.1002/ibd.20923
136. Monteleone G., Pallone F., Macdonald T. T., Interleukin-21 as a new therapeutic target for immune-mediated diseases. Trends in Pharmacological Sciences 2009 30 8 441 447 2-s2.0-67849120058 10.1016/j.tips.2009.05.006
137. Liu Z. J., Geboes K., Colpaert S., D'Haens G. R., Rutgeerts P., Ceuppens J. L., IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. Journal of Immunology 2000 164 7 3608 3615 2-s2.0-0034176003 (Pubitemid 30169814)
138. Kobori A., Yagi Y., Imaeda H., Ban H., Bamba S., Tsujikawa T., Saito Y., Fujiyama Y., Andoh A., Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. Journal of Gastroenterology 2010 45 10 999 1007 2-s2.0-78249249625 10.1007/s00535-010-0245-1
139. Pastorelli L., Garg R. R., Hoang S. B., Spina L., Mattioli B., Scarpa M., Fiocchi C., Vecchi M., Pizarro T. T., Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 17 8017 8022 2-s2.0-77952324145 10.1073/pnas.0912678107
140. Seidelin J. B., Bjerrum J. T., Coskun M., Widjaya B., Vainer B., Nielsen O. H., IL-33 is upregulated in colonocytes of ulcerative colitis. Immunology Letters 2010 128 1 80 85 2-s2.0-74649085973 10.1016/j.imlet.2009.11.001
141. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T. K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D. M., Bazan J. F., Kastelein R. A., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005 23 5 479 490 2-s2.0-27744446058 10.1016/j.immuni.2005.09.015 (Pubitemid 41587888)
142. Wood I. S., Wang B., Trayhurn P., IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochemical and Biophysical Research Communications 2009 384 1 105 109 2-s2.0-65549163320 10.1016/j.bbrc.2009.04.081
143. Moussion C., Ortega N., Girard J. P., The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel "Alarmin"? PLoS ONE 2008 3 10 2-s2.0-53749093767 10.1371/journal.pone.0003331 e3331
144. Xu D., Chan W. L., Leung B. P., Hunter D., Schulz K., Carter R. W., McInnes I. B., Robinson J. H., Liew F. Y., Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. Journal of Experimental Medicine 1998 188 8 1485 1492 2-s2.0-3643120790 10.1084/jem.188.8.1485 (Pubitemid 28489585)
145. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., Busslinger M., Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO Journal 1994 13 5 1176 1188 2-s2.0-0028204189 (Pubitemid 24074724)
146. Oshikawa K., Yanagisawa K., Tominaga S. I., Sugiyama Y., ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochemical and Biophysical Research Communications 2002 299 1 18 24 2-s2.0-0036434818 10.1016/S0006-291X(02)02578-0 (Pubitemid 35366029)
147. Hayakawa H., Hayakawa M., Kume A., Tominaga S. I., Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. Journal of Biological Chemistry 2007 282 36 26369 26380 2-s2.0-34548825396 10.1074/jbc.M704916200 (Pubitemid 47443815)
148. Tominaga S. I., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Komatsu N., Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7/GM. Biochemical and Biophysical Research Communications 1999 264 1 14 18 2-s2.0-0033554599 10.1006/bbrc.1999.1469 (Pubitemid 29500455)
149. Iwahana H., Hayakawa M., Kuroiwa K., Tago K., Yanagisawa K., Noji S., Tominaga S. I., Molecular cloning of the chicken ST2 gene and a novel variant form of the ST2 gene product, ST2LV. Biochimica et Biophysica Acta 2004 1681 1 1 14 2-s2.0-9244222725 10.1016/j.bbaexp.2004.08.013 (Pubitemid 39550366)
150. Palmer G., Lipsky B. P., Smithgall M. D., Meininger D., Siu S., Talabot-Ayer D., Gabay C., Smith D. E., The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008 42 3 358 364 2-s2.0-44449104907 10.1016/j.cyto.2008.03.008
151. Bulek K., Swaidani S., Qin J., Lu Y., Gulen M. F., Herjan T., Min B., Kastelein R. A., Aronica M., Kosz-Vnenchak M., Li X., The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. Journal of Immunology 2009 182 5 2601 2609 2-s2.0-64849087206 10.4049/jimmunol.0802729
152. Ali S., Mohs A., Thomas M., Klare J., Ross R., Schmitz M. L., The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. Journal of Immunology 2011 187 1609 1616
153. Talabot-Ayer D., Lamacchia C., Gabay C., Palmer G., Interleukin-33 is biologically active independently of caspase-1 cleavage. Journal of Biological Chemistry 2009 284 29 19420 19426 2-s2.0-67651053209 10.1074/jbc.M901744200
154. Kakkar R., Hei H., Dobner S., Lee R. T., Interleukin 33 as a mechanically responsive cytokine secreted by living cells. Journal of Biological Chemistry 2012 287 6941 6948
155. Lucey D. R., Clerici M., Shearer G. M., Type 1, and Type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clinical Microbiology Reviews 1996 9 4 532 562 2-s2.0-0029859871 (Pubitemid 26366537)
156. Seder R. A., Acquisition of lymphokine-producing phenotype by CD4+ T cells. Journal of Allergy and Clinical Immunology 1994 94 6 1195 1202 2-s2.0-0028577516 10.1016/0091-6749(94)90332-8
157. Shuai K., Liu B., Regulation of JAK-STAT signalling in the immune system. Nature Reviews Immunology 2003 3 11 900 911 2-s2.0-0242468041 (Pubitemid 37411719)
158. Ahn D. H., Crawley S. C., Hokari R., Kato S., Yang S. C., Li J. D., Kim Y. S., TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cellular Physiology and Biochemistry 2005 15 1-4 29 40 2-s2.0-12444252936 10.1159/000083636
159. Wills-Karp M., Rani R., Dienger K., Lewkowich I., Fox J. G., Perkins C., Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. Journal of Experimental Medicine 2012 209 607 622
160. Nelson M. P., Christmann B. S., Werner J. L., Metz A. E., Trevor J. L., Lowell C. A., Steele C., IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina. Journal of Immunology 2011 186 4 2372 2381 2-s2.0-79951815692 10.4049/jimmunol.1002558
161. Ohno T., Oboki K., Kajiwara N., Morii E., Aozasa K., Flavell R. A., Okumura K., Saito H., Nakae S., Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. Journal of Immunology 2009 183 12 7890 7897 2-s2.0-76249084409 10.4049/jimmunol.0802449
162. Ohno T., Oboki K., Morita H., Kajiwara N., Arae K., Tanaka S., Ikeda M., Iikura M., Akiyama T., Inoue J. I., Matsumoto K., Sudo K., Azuma M., Okumura K., Kamradt T., Saito H., Nakae S., Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLoS ONE 2011 6 4 2-s2.0-79954556380 10.1371/journal.pone.0018404 e18404
163. Hueber A. J., Alves-Filho J. C., Asquith D. L., Michels C., Millar N. L., Reilly J. H., Graham G. J., Liew F. Y., Miller A. M., McInnes I. B., IL-33 induces skin inflammation with mast cell and neutrophil activation. European Journal of Immunology 2011 41 8 2229 2237 2-s2.0-79960732317 10.1002/eji.201041360
164. Suzukawa M., Iikura M., Koketsu R., Nagase H., Tamura C., Komiya A., Nakae S., Matsushima K., Ohta K., Yamamoto K., Yamaguchi M., An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. Journal of Immunology 2008 181 9 5981 5989 2-s2.0-58149257537
165. Schneider E., Petit-Bertron A. F., Bricard R., Levasseur M., Ramadan A., Girard J. P., Herbelin A., Dy M., IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. Journal of Immunology 2009 183 6 3591 3597 2-s2.0-70349337464 10.4049/jimmunol.0900328
166. Iikura M., Suto H., Kajiwara N., Oboki K., Ohno T., Okayama Y., Saito H., Galli S. J., Nakae S., IL-33 can promote survival, adhesion and cytokine production in human mast cells. Laboratory Investigation 2007 87 10 971 978 2-s2.0-34548719890 10.1038/labinvest.3700663 (Pubitemid 47429189)
167. Ho L. H., Ohno T., Oboki K., Kajiwara N., Suto H., Iikura M., Okayama Y., Akira S., Saito H., Galli S. J., Nakae S., IL-33 induces IL-13 production by mouse mast cells independently of IgE-Fc ε RI signals. Journal of Leukocyte Biology 2007 82 6 1481 1490 2-s2.0-37249049230 10.1189/jlb.0407200 (Pubitemid 350276960)
168. Cherry W. B., Yoon J., Bartemes K. R., Iijima K., Kita H., A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. Journal of Allergy and Clinical Immunology 2008 121 6 1484 1490 2-s2.0-44649129170 10.1016/j.jaci.2008.04.005 (Pubitemid 351787349)
169. Suzukawa M., Koketsu R., Iikura M., Nakae S., Matsumoto K., Nagase H., Saito H., Matsushima K., Ohta K., Yamamoto K., Yamaguchi M., Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Laboratory Investigation 2008 88 11 1245 1253 2-s2.0-54949103126 10.1038/labinvest.2008.82
170. Rank M. A., Kobayashi T., Kozaki H., Bartemes K. R., Squillace D. L., Kita H., IL-33-activated dendritic cells induce an atypical TH2-type response. Journal of Allergy and Clinical Immunology 2009 123 5 1047 1054 2-s2.0-67349084096 10.1016/j.jaci.2009.02.026
171. Lecart S., Lecointe N., Subramaniam A., Alkan S., Ni D., Chen R., Activated, but not resting human Th2 cells, in contrast to Th1 and T regulatory cells, produce soluble ST2 and express low levels of ST2L at the cell surface. European Journal of Immunology 2002 32 2979 2987 (Pubitemid 35238191)
172. Guo L., Wei G., Zhu J., Liao W., Leonard W. J., Zhao K., Paul W., IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proceedings of the National Academy of Sciences of the United States of America 2009 106 32 13463 13468 2-s2.0-69449106110 10.1073/pnas.0906988106